Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study.

den Heijer CD, Penders J, Donker GA, Bruggeman CA, Stobberingh EE.

PLoS One. 2013;8(3):e60497. doi: 10.1371/journal.pone.0060497. Epub 2013 Mar 29.

2.

Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.

Arslan H, Azap OK, Ergönül O, Timurkaynak F; Urinary Tract Infection Study Group.

J Antimicrob Chemother. 2005 Nov;56(5):914-8. Epub 2005 Sep 20.

PMID:
16174685
3.

[In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].

Hoşbul T, Ozyurt M, Baylan O, Bektöre B, Ardiç N, Ceylan S, Erdemoğlu A, Haznedaroğlu T.

Mikrobiyol Bul. 2009 Oct;43(4):645-9. Turkish.

PMID:
20084918
4.

Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections.

Shigemura K, Tanaka K, Adachi M, Yamashita M, Arakawa S, Fujisawa M.

J Infect Chemother. 2011 Oct;17(5):646-51. doi: 10.1007/s10156-011-0241-2. Epub 2011 Apr 14.

PMID:
21487942
5.

Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval.

den Heijer CD, Donker GA, Maes J, Stobberingh EE.

J Antimicrob Chemother. 2010 Oct;65(10):2128-33. doi: 10.1093/jac/dkq286. Epub 2010 Aug 3.

PMID:
20682565
6.

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting.

Kronenberg A, Koenig S, Droz S, Mühlemann K.

Clin Microbiol Infect. 2011 Dec;17(12):1845-51. doi: 10.1111/j.1469-0691.2011.03519.x. Epub 2011 Aug 31.

7.

Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.

Meier S, Weber R, Zbinden R, Ruef C, Hasse B.

Infection. 2011 Aug;39(4):333-40. doi: 10.1007/s15010-011-0132-6. Epub 2011 Jun 25.

PMID:
21706226
8.

Relative fecal abundance of extended-spectrum-β-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women.

Ruppé E, Lixandru B, Cojocaru R, Büke C, Paramythiotou E, Angebault C, Visseaux C, Djuikoue I, Erdem E, Burduniuc O, El Mniai A, Marcel C, Perrier M, Kesteman T, Clermont O, Denamur E, Armand-Lefèvre L, Andremont A.

Antimicrob Agents Chemother. 2013 Sep;57(9):4512-7. doi: 10.1128/AAC.00238-13. Epub 2013 Jul 8.

9.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.

Toner L, Papa N, Aliyu SH, Dev H, Lawrentschuk N, Al-Hayek S.

World J Urol. 2016 Jul;34(7):1031-7. doi: 10.1007/s00345-015-1718-x. Epub 2015 Oct 28.

PMID:
26511749
10.

Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.

Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.

J Microbiol Immunol Infect. 2011 Oct;44(5):364-8. doi: 10.1016/j.jmii.2010.08.012. Epub 2011 Jan 20.

11.

Resistance profiles of urinary tract infections in general practice--an observational study.

Schmiemann G, Gágyor I, Hummers-Pradier E, Bleidorn J.

BMC Urol. 2012 Nov 21;12:33. doi: 10.1186/1471-2490-12-33.

12.

The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.

Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, Flynn RJ, McDermott T, Murphy P, Grainger R, Fennell JP, Thornhill JA.

BJU Int. 2012 Apr;109(8):1198-206. doi: 10.1111/j.1464-410X.2011.10528.x. Epub 2011 Aug 24.

13.

Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval.

De Backer D, Christiaens T, Heytens S, De Sutter A, Stobberingh EE, Verschraegen G.

J Antimicrob Chemother. 2008 Aug;62(2):364-8. doi: 10.1093/jac/dkn197. Epub 2008 May 22.

PMID:
18499768
14.

Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.

Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Urinary Pathogens.

Rev Esp Quimioter. 2007 Mar;20(1):68-76.

15.

Urinary tract infections in general practice patients: diagnostic tests versus bacteriological culture.

Nys S, van Merode T, Bartelds AI, Stobberingh EE.

J Antimicrob Chemother. 2006 May;57(5):955-8. Epub 2006 Mar 22.

PMID:
16554337
16.

Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility.

Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, Stobberingh EE.

Urology. 2010 Aug;76(2):336-40. doi: 10.1016/j.urology.2010.02.052. Epub 2010 May 21.

PMID:
20494416
17.

Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.

McGregor JC, Elman MR, Bearden DT, Smith DH.

BMC Fam Pract. 2013 Feb 22;14:25. doi: 10.1186/1471-2296-14-25.

18.

Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department.

Filiatrault L, McKay RM, Patrick DM, Roscoe DL, Quan G, Brubacher J, Collins KM.

CJEM. 2012 Sep;14(5):295-305.

PMID:
22967697
19.

Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?

Mangin D, Toop L, Chambers S, Ikram R, Harris B.

N Z Med J. 2005 Nov 11;118(1225):U1726.

PMID:
16286940
20.

Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.

Sotto A, De Boever CM, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J.

J Clin Microbiol. 2001 Feb;39(2):438-44.

Supplemental Content

Support Center